TSX:MHCD Holdings Information

TSX:MHCD is an equity ETF with a total of 44 individual holdings. The top holdings are Eli Lilly and Company stock at 7.08%, Johnson & Johnson at 6.42%, Merck & Co. at 5.09%, AbbVie at 5.08%, and Thermo Fisher Scientific at 4.41%.

Total Holdings

Top 10 Percentage

42.55%

Asset Class

Equity

ETF Category

Health Care

Assets

160.17M

PE Ratio

24.24

Breakdown by Sector

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	LLY	Eli Lilly and Company	7.08%	7,100
2	JNJ	Johnson & Johnson	6.42%	28,000
3	MRK	Merck & Co., Inc.	5.09%	40,000
4	ABBV	AbbVie Inc.	5.08%	23,000
5	TMO	Thermo Fisher Scientific Inc.	4.41%	8,300
6	LON: AZN	AstraZeneca PLC	3.29%	23,500
7	SYK	Stryker Corporation	2.93%	10,500
8	DHR	Danaher Corporation	2.91%	15,800
9	ABT	Abbott Laboratories	2.76%	29,000
10	MDT	Medtronic plc	2.58%	33,000
11	SWX: NOVN	Novartis AG	2.50%	19,000
12	UNH	UnitedHealth Group Incorporated	2.35%	7,000
13	ISRG	Intuitive Surgical, Inc.	2.31%	7,100
14	BMY	Bristol-Myers Squibb Company	2.25%	39,000
15	TSX: CSH.UN	Chartwell Retirement Residences	2.24%	175,000
16	NTRA	Natera, Inc.	2.22%	8,000
17	VRTX	Vertex Pharmaceuticals Incorporated	2.21%	4,700
18	TSX: EXE	Extendicare Inc.	2.19%	115,000
19	MCK	McKesson Corporation	2.14%	2,800
20	SWX: ROP	Roche Holding AG	2.11%	5,600
21	AMGN	Amgen Inc.	1.96%	5,300
22	WAT	Waters Corporation	1.93%	5,400
23	GILD	Gilead Sciences, Inc.	1.89%	15,000
24	INBX	Inhibrx Biosciences, Inc.	1.80%	16,500
25	HUM	Humana Inc.	1.75%	5,300

Showing 25 of 44 holdings

Subscribe to see the full list

Activate Now

As of Aug 31, 2026